Profil Financier
David Dean Halbert occupe actuellement le rang #1155 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $3.7 B (+$300 sur 24h).
David Dean Halbert became a billionaire in June 2025 when the diagnostics firm he built up, Caris Life Sciences, went public on the Nasdaq.
In 2008 Halbert acquired a small biotech firm called Molecular Profiling Institute, then greatly expanded it and renamed it Caris Life Sciences; he owns a 44% stake.
Caris Life Sciences uses gene sequencing, AI and machine learning for early disease detection; revenue at the unprofitable company grew to $412 million in 2024.
Halbert previously founded pharmacy benefit manager AdvancePCS in 1987. He took it public and later sold it to Caremark for $7.5 billion in 2004
He has been an active buyer and seller of healthcare businesses through his Caris Capital.